The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease ...
The Food and Drug Administration (FDA) has approved Enbumyst ™, a nasal spray formulation of bumetanide, for the treatment of edema associated with congestive heart failure (CHF), and hepatic and ...
This spray formulation of bumetanide demonstrated a 33% faster absorption rate than oral bumetanide, according to clinical ...
Nevada-based Corstasis Therapeutics (Corstasis) has announced FDA’s approval of its bumetanide nasal spray, Enbumyst, for the ...
A single dose of neffy epinephrine nasal spray resulted in successful treatment of anaphylaxis symptoms during oral food ...
A common nasal spray may lower the risk of getting Covid-19, a new study shows. Dr. Leana Wen discusses what this all means as coronavirus cases rise.
KTVU FOX 2 on MSN
This over-the-counter spray could protect you from COVID-19: study
New breakthrough research suggests that a common, over-the-counter nasal spray used to treat allergies may protect against ...
The performance of ARS Pharmaceuticals’ Neffy marginally outpaced historical reports of epinephrine injection effectiveness.
This year also brings something new: The FDA has approved a self-administered version of a nasal spray you can use at home. It arrives temperature-controlled, with two premeasured doses, one for each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback